We have previously demonstrated that CK2 plays an important role in priming the activity of Akt through phosphorylation at S129, and that controlling CK2 activity is an effective strategy in preventing cell growth in BRAF melanoma and BRAF thyroid carcinoma (43). This evidence concerns the gene AKT1 and thyroid gland carcinoma.